Device Orthopedics

Osteoboost Select 5cc

Payments companies reported to CMS as associated with Osteoboost Select 5cc. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$24Kassociated payments (2023-2025)
146clinicians with associated payments
1company reporting

By year

2025 $24K

Payments reported as associated with Osteoboost Select 5cc, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $11K
Adult Reconstructive Orthopaedic Surgery $8,437
Physician Assistant $1,246
Sports Medicine (Orthopaedic Surgery) $1,105
Surgical $492
Podiatrist $426

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Osteoboost Select 5cc

These are the largest totals companies reported as associated with Osteoboost Select 5cc. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Robert Meneghini Indianapolis, IN Adult Reconstructive Orthopaedic Surgery $5,301.16
Saman Vojdani Atlanta, GA Orthopaedic Surgery $375.76
Sarav Shah Brighton, MA Sports Medicine (Orthopaedic Surgery) $263.60
Everett Young Watkinsville, GA Adult Reconstructive Orthopaedic Surgery $216.57
Thomas Bradbury Atlanta, GA Adult Reconstructive Orthopaedic Surgery $216.57
Brian Seng Canton, GA Orthopaedic Surgery $216.57
William Godfrey Sandy Springs, GA Adult Reconstructive Orthopaedic Surgery $216.57
Kaley Puzynski Elkhart, IN Physician Assistant $216.57
Chase Dean Tucker, GA Adult Reconstructive Orthopaedic Surgery $216.57
James Browne Charlottesville, VA Adult Reconstructive Orthopaedic Surgery $216.57

Prescribed Osteoboost Select 5cc?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.